Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

$2.94

Movement

0.21 (-6.67%)

as at 6 May - Closed (20 mins delayed)

52 Week Range

$1.075 - $3.32

 
1 Year Return

+127.91%

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $36.36 billion
P/E Ratio 679.55
Dividend Yield 0.32%
Shares Outstanding 11.54 billion
Earnings per share -0.009
Dividend per share 0.01
Year To Date Return 18.32%
Earnings Yield 0.15%
Franking -
Share Price

$2.94

Day Change

0.21 (-6.67%)

52 Week Range

$1.075 - $3.32

Yesterday's Close

$3.15

Today's Open

$3.09

Days Range

$2.93 - $3.095

Volume

32,959,722

Avg. Volume (1 month)

26,861,749

Turnover

$98,291,542

as at 6 May - Closed

Sigma Healthcare Ltd (ASX: SIG)
Latest News

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a momentous day for ASX shares, with the index hitting another record...

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Sigma share price up 9% on first day of trading post-merger with Chemist Warehouse

It's a post-merger party for Sigma Healthcare shareholders today.

Read more »

Multi-ethnic people looking at camera sitting at public place screaming, shouting and feeling overjoyed about their windfall, good news or sports victory.
Share Market News

ASX 200 strikes new record high

ASX mining stocks and debuting Sigma-Chemist Warehouse shares are soaring today.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the trading week this Friday.

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Healthcare Shares

Why is the Sigma share price soaring 6%?

Sigma has upgraded its FY25 guidance ahead of the anticipated Chemist Warehouse merger completion.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Domino's, Nick Scali, REA, and Sigma shares are charging higher today

These shares are ending the week on a high. Let's see why investors are bidding them higher today.

Read more »

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
Dividend Investing

What role did dividends play in the total returns for each ASX 200 market sector in 2024?

We reveal how much dividends contributed to the total returns of each market sector in 2024.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Sigma share price drops after shareholders vote on Chemist Warehouse merger

The results are in.

Read more »

Man with his hand out the front, symbolising a trading halt.
Healthcare Shares

Halted: What's going on with Sigma shares today?

Sigma investors would be holding their breath right now.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing start to the week for ASX investors this Tuesday.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
01 Oct 2024 $0.0050 0.00% Interim 17 Oct 2024
28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
31 Mar 2009 $0.0400 100.00% Final 07 May 2009
30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

SIG ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Sigma Healthcare Ltd

Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The firm operates through the Amcal, Guardian, PharmaSave, Chemist King, and Discount Drug Stores retail brands. It also involves in the provision of services to retail pharmacists in Australia. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.

SIG Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 May 2025 $3.15 $0.05 1.61% 27,153,512 $3.10 $3.16 $3.08
02 May 2025 $3.10 $0.09 2.99% 53,619,932 $3.03 $3.10 $3.02
01 May 2025 $3.01 $-0.01 -0.33% 28,087,445 $3.05 $3.09 $3.01
30 Apr 2025 $3.02 $0.00 0.00% 27,407,111 $3.02 $3.04 $3.00
29 Apr 2025 $3.02 $0.01 0.33% 18,498,204 $3.01 $3.03 $3.00
28 Apr 2025 $3.01 $0.00 0.00% 26,879,063 $3.01 $3.03 $2.99
24 Apr 2025 $3.01 $-0.06 -1.95% 18,131,333 $3.05 $3.06 $3.00
23 Apr 2025 $3.07 $0.12 4.07% 37,623,760 $3.00 $3.08 $2.98
22 Apr 2025 $2.95 $-0.03 -1.01% 12,487,291 $2.96 $2.99 $2.94
17 Apr 2025 $2.98 $-0.01 -0.33% 27,722,891 $2.99 $3.02 $2.98
16 Apr 2025 $2.99 $0.00 0.00% 18,757,612 $3.00 $3.02 $2.96
15 Apr 2025 $2.99 $-0.01 -0.33% 11,768,807 $3.00 $3.02 $2.98
14 Apr 2025 $3.00 $0.00 0.00% 21,907,222 $3.00 $3.03 $2.98
11 Apr 2025 $3.00 $0.00 0.00% 23,246,464 $2.97 $3.01 $2.95
10 Apr 2025 $3.00 $0.07 2.39% 30,596,381 $3.00 $3.02 $2.96
09 Apr 2025 $2.93 $-0.04 -1.35% 28,528,445 $2.93 $3.00 $2.91
08 Apr 2025 $2.97 $0.15 5.32% 33,609,833 $2.82 $2.98 $2.81
07 Apr 2025 $2.82 $-0.07 -2.42% 37,486,182 $2.77 $2.86 $2.72

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Apr 2025 Damien Gance Sell 100,000,000 $297,000,000
Off-market trade.
14 Feb 2025 Damien Gance Sell 40,000,000 $120,000,000
Off-market trade.
14 Feb 2025 Vikesh Ramsunder Buy 1,965,878 $6,133,539
Conversion of securities.
14 Feb 2025 Vikesh Ramsunder Exercise 1,965,878 $6,133,539
Conversion of securities. 1,010,723 - Rights
13 Feb 2025 Vikesh Ramsunder Sell 11,662,028 $34,053,121
On-market trade. Average Price
12 Feb 2025 Vikesh Ramsunder Buy 1,167,106 $3,221,212
Conversion of securities.
12 Feb 2025 Vikesh Ramsunder Exercise 1,167,106 $3,221,212
Conversion of securities. 4,921,778 - Rights
12 Feb 2025 Vikesh Ramsunder Expiry 1,945,177 $5,368,688
As advised by the company. 2,976,601 - Rights
lapse of remaining 1,945,177 EEG Rights
10 Jul 2024 Annette Carey Buy 3,662 $4,681
Directors' share plan.
10 Jul 2024 Christopher Roberts Buy 3,661 $4,680
Directors' share plan.
10 Jul 2024 Neville Mitchell Buy 4,340 $5,548
Directors' share plan.
10 Jul 2024 Kathryn (Kate) Spargo Buy 4,747 $6,067
Directors' share plan.
10 Jul 2024 Michael Sammells Buy 7,866 $10,054
Directors' share plan.
09 Jul 2024 Vikesh Ramsunder Issued 1,253,717 $1,611,026
Issue of securities. 6,088,884 - Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Christopher Graham Roberts Non-Executive Director Oct 2023
Dr Roberts has more than 40 years of experience in the medical device industry, including as the former Chief Executive Officer of Cochlear Limited from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. He is currently a non-executive director of HMC Capital Ltd (ASX:HMC). HMC Capital managed HealthcCo Healthcare and Wellness REIT (ASX:HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
Mr Neville Mitchell Non-Executive Director Feb 2023
Mr Mitchell has international healthcare and finance experience. He was Chief Financial Officer and Company Secretary at ASX-listed Cochlear Limited, a world leading medical device developer, manufacturer and seller of hearing devices. Mr Mitchell is currently the Chairman of ASX and NZX-listed Fisher&Paykel Healthcare Corporation (non-executive director from November 2018) and a non-executive director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He was formerly a non-executive director of ASX-listed Sirtex Healthcare, Osprey Medical Inc and Q'Biotics Group Limited. He has also performed roles with several industry and Government committees.
Mr Michael Sammells Non-Executive DirectorNon-Executive Chairman Feb 2020
Mr Sammells is also currently a non-executive director at AMP Limited and a director at GMBHA. He has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital development, mergers and acquisitions and IPOs. Further, Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
Mr Ramsunder has experience in pharmacy retailing, wholesaling and logistics. He spent 28 years with the Clicks Group in South Africa. This included 18 years as part of the executive team. Before becoming Clicks Group Chief Executive Officer in January 2019, Mr Ramsunder held several roles within Clicks, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesale business, United Pharmaceutical Distributors from 2010.
Ms Annette May Carey Non-Executive Director Apr 2023
Ms Carey is a current non-executive director of National Intermodal Corporation and a non-executive director of the Kinetic bus group. Prior to joining Sigma, Ms Carey has held director roles within the Linfox group of companies and has been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has previously held various senior roles within the Linfox Logistics group, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
Mr Jack Gance Non-Executive Director Feb 2025
Mr D Gance is a qualified pharmacist who joined MyChemist in 1998 and is currently the Chief Commercial Officer of Chemist Warehouse. Mr D Gance was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000.
Ms Danielle Di Pilla Executive Director Feb 2025
Ms Di Pilla is a qualified pharmacist who is currently the Chief People Officer at Chemist Warehouse. Ms Di Pilla established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla has been the managing director of DPP since it was incorporated. DPP is a wholly owned subsidiary of Chemist Warehouse. Ms Di Pilla also sits on the Board of Gotcha4Life.
Mr Mario Verrocchi Executive Director Feb 2025
Mr Verrocchi joined Jack and Sam Gance's pharmacy group in 1982. Mr Verrocchi established MyChemist with Jack Gance and Sam Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000. He is currently Chief Executive Officer of Chemist Warehouse.
Mr Damien Gance Executive Director Feb 2025
Mr J Gance as a pharmacist in 1967 and opened his first pharmacy store in Reservoir, Victoria, with Sam in 1972. In 1997, Mr J Gance, Sam Gance and Mario Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, Mr J Gance, along with Mr Sam Gance and Mr Verrocchi, established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr J Gance also created the brands Le Specs, Le Tan and Colours of Australis.
Ms Kara McGowan General CounselCompany Secretary Oct 2021
-
Kara McGowan General CounselCompany Secretary
-
Mr M Conway Chief Financial Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 871,241,938 14.61%
Citicorp Nominees Pty Limited 445,477,631 7.47%
J P Morgan Nominees Australia Pty Limited 359,556,170 6.03%
Dgsr Family Foundation Pty Ltd 353,829,615 5.93%
Av Family Foundation Pty Ltd 313,784,873 5.26%
Mjv Family Foundation Pty Ltd 313,784,873 5.26%
Mr Sunil Narula 165,893,114 2.78%
Bond Street Custodians Limited 150,545,209 2.52%
Mat Family Foundation Pty Ltd 148,144,781 2.48%
HMC Capital Partners Holdings Pty Ltd 103,399,008 1.73%
Ms Nancy Fei Fei Jian 86,118,340 1.44%
HSBC Custody Nominees (Australia) Limited Gsco Eca 75,333,468 1.26%
Mr Azman Rashid Haroon 64,502,845 1.08%
Ms Danielle Di Pilla 61,243,218 1.03%
Mr Claudio Avendano 55,986,398 0.94%
Citicorp Nominees Pty Limited i 51,603,737 0.87%
Bond Street Custodians Limited i 48,455,727 0.81%
Di Pilla Investments Pty Ltd 44,228,054 0.74%
Mr William Ho 41,669,145 0.70%
Bond Street Custodians Limited ii 41,505,949 0.73%
Mr Anthony Paul Bassaly 39,768,975 0.67%

Profile

since

Note